Stanisław Burzyński

Revision as of 15:35, 30 November 2011 by Halbmond (talk | contribs) (tp)
Stanisław Burzyński

Stanislaw Rajmund Burzynski (born January 23, 1943 in Lublin, Poland) is a biochemist and a physician. He is the founder, president and chairman of Burzynski Research Institute Inc. , based in Houston and Stafford, Texas. Since December 1976, Burzynski administered peptides and their metabolites, which he calls antineoplastons, as a treatment against cancer.

Legal issues

In 1993, Burzynski was brought to court in Texas for treating patients with a therapy not approved by the Food and Drug Administration (FDA) and for selling antineoplastons in interstate commerce.[1][2] In 1998 the Texas Attorney General, Dan Morales, placed limits on his advertising of antineoplastons[3] and ordered him to cease and desist selling his products without FDA supervised clinical trials.[4] Burzynski appealed the limitations on his advertising on the grounds of free speech, but the appeal court upheld the decision, stating that "Burzynski's commercial speech does not concern a lawful activity."[1] Burzynski was also found guilty of fraud in 1994, as he claimed reimbursement from a health insurer for a cancer treatment administered illegally.[4] Burzynski will have a hearing with the Texas Medical Board in April 2012. The board might well revoke his approbation.

Main Article: Antineoplaston

Links

  1. 1.0 1.1 Texas State Board of Medical Examiners, Appellant v. Stanislaw R. Burzynski, M.D., Ph.D., Appellee Court judgement
  2. Cite error: Invalid <ref> tag; no text was provided for refs named openjurist1987
  3. Template:Cite web
  4. 4.0 4.1 No. 93-2071 July 28, 1994. United States Court of Appeals, Fifth Circuit summary judgment.